Immunocore Holdings (IMCR) Other Non Operating Income (2023 - 2026)

Immunocore Holdings has disclosed Other Non Operating Income across 4 years of filings, most recently posting $3.8 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $3.8 million, down 29.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.2 million (up 968.94% YoY), and the FY2025 annual result was $19.7 million, up 672.16% from the prior year.
• Other Non Operating Income came in at $3.8 million for Q1 2026 at Immunocore Holdings, down from $16.1 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $16.1 million in Q4 2025 to a low of -$16.7 million in Q4 2024.
• The 4-year median for Other Non Operating Income is $3.8 million (2026), against an average of $620923.1.
• Peak annual rise in Other Non Operating Income reached 2978.42% in 2025, while the deepest fall reached 116.65% in 2025.
• Immunocore Holdings' Other Non Operating Income stood at -$12.5 million in 2023, then plunged by 32.92% to -$16.7 million in 2024, then jumped by 196.4% to $16.1 million in 2025, then slumped by 76.02% to $3.8 million in 2026.
• The last three Other Non Operating Income figures came in at $3.8 million (Q1 2026), $16.1 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.